45.68
0.15 (0.33%)
| Penutupan Terdahulu | 45.53 |
| Buka | 45.17 |
| Jumlah Dagangan | 641,719 |
| Purata Dagangan (3B) | 486,488 |
| Modal Pasaran | 1,443,989,376 |
| Harga / Pendapatan (P/E TTM) | 28.02 |
| Harga / Pendapatan (P/E Ke hadapan) | 6.33 |
| Harga / Jualan (P/S) | 2.46 |
| Harga / Buku (P/B) | 5.41 |
| Julat 52 Minggu |
| Margin Keuntungan | 6.61% |
| Margin Operasi (TTM) | 13.71% |
| EPS Cair (TTM) | 1.22 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 22.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -91.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 411.94% |
| Nisbah Semasa (MRQ) | 1.08 |
| Aliran Tunai Operasi (OCF TTM) | 198.44 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 341.32 M |
| Pulangan Atas Aset (ROA TTM) | 7.95% |
| Pulangan Atas Ekuiti (ROE TTM) | 19.23% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Menaik | Menaik | |
| Stok | Collegium Pharmaceutical, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -0.5 |
| Purata | 1.00 |
|
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 1.69% |
| % Dimiliki oleh Institusi | 117.12% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 60.00 (HC Wainwright & Co., 31.35%) | Beli |
| Median | 56.00 (22.59%) | |
| Rendah | 48.00 (Truist Securities, 5.08%) | Beli |
| Purata | 55.00 (20.40%) | |
| Jumlah | 4 Beli | |
| Harga Purata @ Panggilan | 45.54 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Barclays | 09 Jan 2026 | 56.00 (22.59%) | Beli | 45.54 |
| 09 Dec 2025 | 58.00 (26.97%) | Beli | 47.03 | |
| HC Wainwright & Co. | 09 Jan 2026 | 60.00 (31.35%) | Beli | 45.54 |
| 07 Nov 2025 | 46.00 (0.70%) | Beli | 42.30 | |
| Needham | 08 Jan 2026 | 56.00 (22.59%) | Beli | 48.78 |
| 28 Oct 2025 | 46.00 (0.70%) | Beli | 35.41 | |
| Truist Securities | 07 Nov 2025 | 48.00 (5.08%) | Beli | 42.30 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 15 Jan 2026 | Pengumuman | Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference |
| 08 Jan 2026 | Pengumuman | Collegium Provides 2026 Financial Guidance and Business Update |
| 30 Dec 2025 | Pengumuman | Collegium Announces the Closing of $980 Million Syndicated Credit Facility |
| 12 Nov 2025 | Pengumuman | Collegium to Participate in Upcoming Investor Conferences |
| 06 Nov 2025 | Pengumuman | Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance |
| 29 Oct 2025 | Pengumuman | Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment |
| 23 Oct 2025 | Pengumuman | Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |